Skip to main content
Clinical Trials/DRKS00014031
DRKS00014031
Completed
未知

Interventional study to evaluate the safety, reliability and validity of the medical device Nimble in comparison to established devices for objective assessment of scar maturation (Cutometer®) and subjective assessment (POSAS) in children after partial deep dermal or full thickness burns - Nimble – novel objective assessment of scar maturation

niversitätskinderspital Zürich0 sites40 target enrollmentFebruary 12, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Burns, scald (T20-35), scar (L90.5),
Sponsor
niversitätskinderspital Zürich
Enrollment
40
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 12, 2018
End Date
August 23, 2019
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversitätskinderspital Zürich

Eligibility Criteria

Inclusion Criteria

  • Male and female patients \= 1 y , \= 18 y
  • Scars or transplants resulting from burns \= 1month , \= 10 years, at any location of the body
  • Signed Informed consent from the patient or the legally authorized representative
  • \-\-\-\-\-\-\-\-\-
  • Male and female patients \= 1 y , \= 18 y
  • Burn wounds \< 3 month ago, not requiring surgical wound coverage but healing with scar tissue, at any location of the body
  • Deep partial thickness and/or full thickness burns \< 3 month ago, requiring surgical wound coverage, at any location of the body
  • Signed Informed consent from the patient or the legally authorized representative

Exclusion Criteria

  • Part A and B:
  • Patients with known underlying or concomitant medical conditions that may interfere with normal wound healing (e.g. systemic skin and connective tissues diseases, e.g. epidermolysis bullosa or congenital metabolic disease directly influencing wound healing)
  • Inability to follow the procedures of the study, e.g. due to language problems.
  • Patients with unhealed wounds at or in the proximity of the measurement sites, persisting at the time of measurements with the interventional device or the control device (Cutometer®).
  • Enrolment of the Investigator, his/her family members, employees and other dependent persons.

Outcomes

Primary Outcomes

Not specified

Similar Trials